Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

0610006L08Rik Inhibitors

Understanding the intricate mechanisms by which gene expression is controlled within a cell is a cornerstone of molecular biology. The gene 0610006L08Rik, although not extensively characterized in the literature, is one such gene whose expression is subject to a complex array of regulatory controls. Gene expression can be fine-tuned at multiple levels, from epigenetic modifications to the interaction with transcription factors and the interplay with various signaling pathways. The expression of 0610006L08Rik, akin to other genes, may be influenced by a diverse set of chemical compounds that specifically target these regulatory mechanisms. For instance, certain chemicals are known to alter the epigenetic landscape by affecting DNA methylation patterns or modifying histone proteins-both of which are crucial for the chromatin structure that dictates gene accessibility to transcriptional machinery.

Chemical compounds such as DNA methyltransferase inhibitors, histone deacetylase inhibitors, and specific pathway inhibitors have been shown to play pivotal roles in the modulation of gene expression. In the context of 0610006L08Rik, DNA methyltransferase inhibitors like 5-Azacytidine and Decitabine could potentially lead to the demethylation of cytosine bases within the gene's promoter region, thereby reducing its expression. Similarly, histone deacetylase inhibitors such as Trichostatin A and Sodium Butyrate might cause an increase in histone acetylation, resulting in a less compact chromatin structure and a consequent decrease in the expression of the gene. Moreover, inhibitors targeting various cell signaling cascades-such as Sirolimus for the mTOR pathway, LY294002 for the PI3K pathway, and SP600125 for the JNK pathway-could also downregulate the expression of 0610006L08Rik by impeding the signaling required for gene activation. These compounds demonstrate the potential to influence gene expression through distinct but interconnected biochemical pathways, underscoring the multi-layered regulation of genes such as 0610006L08Rik within cellular systems.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By incorporating into DNA where it replaces cytidine, 5-Azacytidine could lead to the demethylation of the 0610006L08Rik gene promoter, subsequently decreasing its transcriptional activity.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A could remove acetyl groups from histones near the 0610006L08Rik locus, leading to a more condensed chromatin state and thus downregulating the gene's expression.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Mithramycin A might bind to the GC-rich regions of DNA in the control elements of 0610006L08Rik, obstructing access to essential transcriptional machinery and consequently inhibiting its transcription.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D intercalates into DNA duplexes, potentially disrupting RNA polymerase movement along the DNA template of 0610006L08Rik, thereby halting its mRNA synthesis.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin (Sirolimus) could suppress the mTOR signaling pathway, which may be necessary for the expression of 0610006L08Rik, culminating in decreased gene expression.

RG 108

48208-26-0sc-204235
sc-204235A
10 mg
50 mg
$131.00
$515.00
2
(1)

RG 108 might directly inhibit the activity of DNA methyltransferases, potentially leading to the reduced methylation of the 0610006L08Rik promoter and a consequent drop in its expression.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

5-Aza-2′-Deoxycytidine, an analog of cytidine, might be incorporated into the DNA of 0610006L08Rik during replication, causing the hypomethylation and a subsequent reduction in its expression.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium Butyrate could inhibit histone deacetylases, leading to hyperacetylation of histones associated with 0610006L08Rik and a subsequent decrease in its gene expression.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine might disrupt lysosomal acidification, which could alter the cellular environment and lead to a decrease in the expression of genes like 0610006L08Rik by hindering transcription factor recycling.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic Acid could bind to its nuclear receptors which may be involved in the transcriptional repression of 0610006L08Rik, leading to decreased expression levels.